Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy.
Schamun
Alejandro
A
Bullorsky
Eduardo
E
Stemmelin
German
G
Saxton
Ricardo
R
Ricchione
Daniel
D
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D016572:Cyclosporine / Q000008:administration & dosage*; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D016572:Cyclosporine; D000068877:Imatinib Mesylate